カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ファーマ4.0の世界市場見通し2023年-2029年

◆英語タイトル：Pharma 4.0 Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5900）◆商品コード：MMG23JU5900
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：102
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Pharma 4.0 Market 調査レポートは次の情報を含め、グローバルにおけるのファーマ4.0市場規模と予測を収録しています。・世界のファーマ4.0市場：売上、2018年-2023年、2024年-2029年
・世界のファーマ4.0市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のファーマ4.0市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「クラウド」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ファーマ4.0のグローバル主要企業は、Pfizer Inc、 Abbott Laboratories、 GE Healthcare、 Boston Scientific、 Medtronic Plc.、 Lonza Group AG、 GlaxoSmithKline plc.、 Koninklijke Philips N.V.、 Glatt GmbH、 Vertex、 Johnson & Johnson、 Goodly Innovations、 QbDVision、 Electrosan、 GoSilico、 Smart Factoryなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ファーマ4.0のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のファーマ4.0市場：タイプ別、2018年-2023年、2024年-2029年
世界のファーマ4.0市場：タイプ別市場シェア、2022年
・クラウド、オンプレミス

世界のファーマ4.0市場：用途別、2018年-2023年、2024年-2029年
世界のファーマ4.0市場：用途別市場シェア、2022年
・製薬産業、IoT産業、医療機器産業、その他

世界のファーマ4.0市場：地域・国別、2018年-2023年、2024年-2029年
世界のファーマ4.0市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるファーマ4.0のグローバル売上、2018年-2023年
・主要企業におけるファーマ4.0のグローバル売上シェア、2022年
・主要企業におけるファーマ4.0のグローバル販売量、2018年-2023年
・主要企業におけるファーマ4.0のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer Inc、 Abbott Laboratories、 GE Healthcare、 Boston Scientific、 Medtronic Plc.、 Lonza Group AG、 GlaxoSmithKline plc.、 Koninklijke Philips N.V.、 Glatt GmbH、 Vertex、 Johnson & Johnson、 Goodly Innovations、 QbDVision、 Electrosan、 GoSilico、 Smart Factory

*************************************************************

・調査・分析レポートの概要
ファーマ4.0市場の定義
市場セグメント
世界のファーマ4.0市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のファーマ4.0市場規模
世界のファーマ4.0市場規模：2022年 VS 2029年
世界のファーマ4.0市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのファーマ4.0の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のファーマ4.0製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：クラウド、オンプレミス
ファーマ4.0のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：製薬産業、IoT産業、医療機器産業、その他
ファーマ4.0の用途別グローバル売上・予測

・地域別市場分析
地域別ファーマ4.0市場規模 2022年と2029年
地域別ファーマ4.0売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer Inc、 Abbott Laboratories、 GE Healthcare、 Boston Scientific、 Medtronic Plc.、 Lonza Group AG、 GlaxoSmithKline plc.、 Koninklijke Philips N.V.、 Glatt GmbH、 Vertex、 Johnson & Johnson、 Goodly Innovations、 QbDVision、 Electrosan、 GoSilico、 Smart Factory
...

Pharma 4.0 is a holistic operating model for pharmaceutical factories and supply chains of the future based on Industry 4.0 capabilities, digital maturity, and data integrity by design.Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. In practical terms, it means more connectivity, more productivity, simplified compliance, and the marshaling of production information to respond to problems as they emerge.
This report aims to provide a comprehensive presentation of the global market for Pharma 4.0, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma 4.0. This report contains market size and forecasts of Pharma 4.0 in global, including the following market information:
Global Pharma 4.0 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pharma 4.0 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cloud Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharma 4.0 include Pfizer Inc, Abbott Laboratories, GE Healthcare, Boston Scientific, Medtronic Plc., Lonza Group AG, GlaxoSmithKline plc., Koninklijke Philips N.V. and Glatt GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma 4.0 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma 4.0 Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pharma 4.0 Market Segment Percentages, by Type, 2022 (%)
Cloud
On-premise
Global Pharma 4.0 Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pharma 4.0 Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Industry
IoT Industry
Medical Equipment Industry
Others
Global Pharma 4.0 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pharma 4.0 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma 4.0 revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharma 4.0 revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc
Abbott Laboratories
GE Healthcare
Boston Scientific
Medtronic Plc.
Lonza Group AG
GlaxoSmithKline plc.
Koninklijke Philips N.V.
Glatt GmbH
Vertex
Johnson & Johnson
Goodly Innovations
QbDVision
Electrosan
GoSilico
Smart Factory
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharma 4.0, market overview.
Chapter 2: Global Pharma 4.0 market size in revenue.
Chapter 3: Detailed analysis of Pharma 4.0 company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharma 4.0 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Pharma 4.0 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharma 4.0 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharma 4.0 Overall Market Size
2.1 Global Pharma 4.0 Market Size: 2022 VS 2029
2.2 Global Pharma 4.0 Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharma 4.0 Players in Global Market
3.2 Top Global Pharma 4.0 Companies Ranked by Revenue
3.3 Global Pharma 4.0 Revenue by Companies
3.4 Top 3 and Top 5 Pharma 4.0 Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharma 4.0 Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharma 4.0 Players in Global Market
3.6.1 List of Global Tier 1 Pharma 4.0 Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharma 4.0 Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Pharma 4.0 Market Size Markets, 2022 & 2029
4.1.2 Cloud
4.1.3 On-premise
4.2 By Type – Global Pharma 4.0 Revenue & Forecasts
4.2.1 By Type – Global Pharma 4.0 Revenue, 2018-2023
4.2.2 By Type – Global Pharma 4.0 Revenue, 2024-2029
4.2.3 By Type – Global Pharma 4.0 Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharma 4.0 Market Size, 2022 & 2029
5.1.2 Pharmaceutical Industry
5.1.3 IoT Industry
5.1.4 Medical Equipment Industry
5.1.5 Others
5.2 By Application – Global Pharma 4.0 Revenue & Forecasts
5.2.1 By Application – Global Pharma 4.0 Revenue, 2018-2023
5.2.2 By Application – Global Pharma 4.0 Revenue, 2024-2029
5.2.3 By Application – Global Pharma 4.0 Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Pharma 4.0 Market Size, 2022 & 2029
6.2 By Region – Global Pharma 4.0 Revenue & Forecasts
6.2.1 By Region – Global Pharma 4.0 Revenue, 2018-2023
6.2.2 By Region – Global Pharma 4.0 Revenue, 2024-2029
6.2.3 By Region – Global Pharma 4.0 Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Pharma 4.0 Revenue, 2018-2029
6.3.2 US Pharma 4.0 Market Size, 2018-2029
6.3.3 Canada Pharma 4.0 Market Size, 2018-2029
6.3.4 Mexico Pharma 4.0 Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Pharma 4.0 Revenue, 2018-2029
6.4.2 Germany Pharma 4.0 Market Size, 2018-2029
6.4.3 France Pharma 4.0 Market Size, 2018-2029
6.4.4 U.K. Pharma 4.0 Market Size, 2018-2029
6.4.5 Italy Pharma 4.0 Market Size, 2018-2029
6.4.6 Russia Pharma 4.0 Market Size, 2018-2029
6.4.7 Nordic Countries Pharma 4.0 Market Size, 2018-2029
6.4.8 Benelux Pharma 4.0 Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Pharma 4.0 Revenue, 2018-2029
6.5.2 China Pharma 4.0 Market Size, 2018-2029
6.5.3 Japan Pharma 4.0 Market Size, 2018-2029
6.5.4 South Korea Pharma 4.0 Market Size, 2018-2029
6.5.5 Southeast Asia Pharma 4.0 Market Size, 2018-2029
6.5.6 India Pharma 4.0 Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Pharma 4.0 Revenue, 2018-2029
6.6.2 Brazil Pharma 4.0 Market Size, 2018-2029
6.6.3 Argentina Pharma 4.0 Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Pharma 4.0 Revenue, 2018-2029
6.7.2 Turkey Pharma 4.0 Market Size, 2018-2029
6.7.3 Israel Pharma 4.0 Market Size, 2018-2029
6.7.4 Saudi Arabia Pharma 4.0 Market Size, 2018-2029
6.7.5 UAE Pharma 4.0 Market Size, 2018-2029
7 Pharma 4.0 Companies Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Pharma 4.0 Major Product Offerings
7.1.4 Pfizer Inc Pharma 4.0 Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Pharma 4.0 Major Product Offerings
7.2.4 Abbott Laboratories Pharma 4.0 Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Company Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Pharma 4.0 Major Product Offerings
7.3.4 GE Healthcare Pharma 4.0 Revenue in Global Market (2018-2023)
7.3.5 GE Healthcare Key News & Latest Developments
7.4 Boston Scientific
7.4.1 Boston Scientific Company Summary
7.4.2 Boston Scientific Business Overview
7.4.3 Boston Scientific Pharma 4.0 Major Product Offerings
7.4.4 Boston Scientific Pharma 4.0 Revenue in Global Market (2018-2023)
7.4.5 Boston Scientific Key News & Latest Developments
7.5 Medtronic Plc.
7.5.1 Medtronic Plc. Company Summary
7.5.2 Medtronic Plc. Business Overview
7.5.3 Medtronic Plc. Pharma 4.0 Major Product Offerings
7.5.4 Medtronic Plc. Pharma 4.0 Revenue in Global Market (2018-2023)
7.5.5 Medtronic Plc. Key News & Latest Developments
7.6 Lonza Group AG
7.6.1 Lonza Group AG Company Summary
7.6.2 Lonza Group AG Business Overview
7.6.3 Lonza Group AG Pharma 4.0 Major Product Offerings
7.6.4 Lonza Group AG Pharma 4.0 Revenue in Global Market (2018-2023)
7.6.5 Lonza Group AG Key News & Latest Developments
7.7 GlaxoSmithKline plc.
7.7.1 GlaxoSmithKline plc. Company Summary
7.7.2 GlaxoSmithKline plc. Business Overview
7.7.3 GlaxoSmithKline plc. Pharma 4.0 Major Product Offerings
7.7.4 GlaxoSmithKline plc. Pharma 4.0 Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline plc. Key News & Latest Developments
7.8 Koninklijke Philips N.V.
7.8.1 Koninklijke Philips N.V. Company Summary
7.8.2 Koninklijke Philips N.V. Business Overview
7.8.3 Koninklijke Philips N.V. Pharma 4.0 Major Product Offerings
7.8.4 Koninklijke Philips N.V. Pharma 4.0 Revenue in Global Market (2018-2023)
7.8.5 Koninklijke Philips N.V. Key News & Latest Developments
7.9 Glatt GmbH
7.9.1 Glatt GmbH Company Summary
7.9.2 Glatt GmbH Business Overview
7.9.3 Glatt GmbH Pharma 4.0 Major Product Offerings
7.9.4 Glatt GmbH Pharma 4.0 Revenue in Global Market (2018-2023)
7.9.5 Glatt GmbH Key News & Latest Developments
7.10 Vertex
7.10.1 Vertex Company Summary
7.10.2 Vertex Business Overview
7.10.3 Vertex Pharma 4.0 Major Product Offerings
7.10.4 Vertex Pharma 4.0 Revenue in Global Market (2018-2023)
7.10.5 Vertex Key News & Latest Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Summary
7.11.2 Johnson & Johnson Business Overview
7.11.3 Johnson & Johnson Pharma 4.0 Major Product Offerings
7.11.4 Johnson & Johnson Pharma 4.0 Revenue in Global Market (2018-2023)
7.11.5 Johnson & Johnson Key News & Latest Developments
7.12 Goodly Innovations
7.12.1 Goodly Innovations Company Summary
7.12.2 Goodly Innovations Business Overview
7.12.3 Goodly Innovations Pharma 4.0 Major Product Offerings
7.12.4 Goodly Innovations Pharma 4.0 Revenue in Global Market (2018-2023)
7.12.5 Goodly Innovations Key News & Latest Developments
7.13 QbDVision
7.13.1 QbDVision Company Summary
7.13.2 QbDVision Business Overview
7.13.3 QbDVision Pharma 4.0 Major Product Offerings
7.13.4 QbDVision Pharma 4.0 Revenue in Global Market (2018-2023)
7.13.5 QbDVision Key News & Latest Developments
7.14 Electrosan
7.14.1 Electrosan Company Summary
7.14.2 Electrosan Business Overview
7.14.3 Electrosan Pharma 4.0 Major Product Offerings
7.14.4 Electrosan Pharma 4.0 Revenue in Global Market (2018-2023)
7.14.5 Electrosan Key News & Latest Developments
7.15 GoSilico
7.15.1 GoSilico Company Summary
7.15.2 GoSilico Business Overview
7.15.3 GoSilico Pharma 4.0 Major Product Offerings
7.15.4 GoSilico Pharma 4.0 Revenue in Global Market (2018-2023)
7.15.5 GoSilico Key News & Latest Developments
7.16 Smart Factory
7.16.1 Smart Factory Company Summary
7.16.2 Smart Factory Business Overview
7.16.3 Smart Factory Pharma 4.0 Major Product Offerings
7.16.4 Smart Factory Pharma 4.0 Revenue in Global Market (2018-2023)
7.16.5 Smart Factory Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Pharma 4.0 Market Opportunities & Trends in Global Market
Table 2. Pharma 4.0 Market Drivers in Global Market
Table 3. Pharma 4.0 Market Restraints in Global Market
Table 4. Key Players of Pharma 4.0 in Global Market
Table 5. Top Pharma 4.0 Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharma 4.0 Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharma 4.0 Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharma 4.0 Product Type
Table 9. List of Global Tier 1 Pharma 4.0 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharma 4.0 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Pharma 4.0 Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pharma 4.0 Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharma 4.0 Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Pharma 4.0 Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pharma 4.0 Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharma 4.0 Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Pharma 4.0 Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pharma 4.0 Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharma 4.0 Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pharma 4.0 Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharma 4.0 Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pharma 4.0 Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharma 4.0 Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pharma 4.0 Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharma 4.0 Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pharma 4.0 Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharma 4.0 Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pharma 4.0 Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharma 4.0 Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Inc Company Summary
Table 31. Pfizer Inc Pharma 4.0 Product Offerings
Table 32. Pfizer Inc Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Inc Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Pharma 4.0 Product Offerings
Table 36. Abbott Laboratories Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. GE Healthcare Company Summary
Table 39. GE Healthcare Pharma 4.0 Product Offerings
Table 40. GE Healthcare Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 41. GE Healthcare Key News & Latest Developments
Table 42. Boston Scientific Company Summary
Table 43. Boston Scientific Pharma 4.0 Product Offerings
Table 44. Boston Scientific Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 45. Boston Scientific Key News & Latest Developments
Table 46. Medtronic Plc. Company Summary
Table 47. Medtronic Plc. Pharma 4.0 Product Offerings
Table 48. Medtronic Plc. Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 49. Medtronic Plc. Key News & Latest Developments
Table 50. Lonza Group AG Company Summary
Table 51. Lonza Group AG Pharma 4.0 Product Offerings
Table 52. Lonza Group AG Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 53. Lonza Group AG Key News & Latest Developments
Table 54. GlaxoSmithKline plc. Company Summary
Table 55. GlaxoSmithKline plc. Pharma 4.0 Product Offerings
Table 56. GlaxoSmithKline plc. Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline plc. Key News & Latest Developments
Table 58. Koninklijke Philips N.V. Company Summary
Table 59. Koninklijke Philips N.V. Pharma 4.0 Product Offerings
Table 60. Koninklijke Philips N.V. Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 61. Koninklijke Philips N.V. Key News & Latest Developments
Table 62. Glatt GmbH Company Summary
Table 63. Glatt GmbH Pharma 4.0 Product Offerings
Table 64. Glatt GmbH Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 65. Glatt GmbH Key News & Latest Developments
Table 66. Vertex Company Summary
Table 67. Vertex Pharma 4.0 Product Offerings
Table 68. Vertex Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 69. Vertex Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Pharma 4.0 Product Offerings
Table 72. Johnson & Johnson Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Goodly Innovations Company Summary
Table 75. Goodly Innovations Pharma 4.0 Product Offerings
Table 76. Goodly Innovations Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 77. Goodly Innovations Key News & Latest Developments
Table 78. QbDVision Company Summary
Table 79. QbDVision Pharma 4.0 Product Offerings
Table 80. QbDVision Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 81. QbDVision Key News & Latest Developments
Table 82. Electrosan Company Summary
Table 83. Electrosan Pharma 4.0 Product Offerings
Table 84. Electrosan Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 85. Electrosan Key News & Latest Developments
Table 86. GoSilico Company Summary
Table 87. GoSilico Pharma 4.0 Product Offerings
Table 88. GoSilico Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 89. GoSilico Key News & Latest Developments
Table 90. Smart Factory Company Summary
Table 91. Smart Factory Pharma 4.0 Product Offerings
Table 92. Smart Factory Pharma 4.0 Revenue (US$, Mn) & (2018-2023)
Table 93. Smart Factory Key News & Latest Developments
List of Figures
Figure 1. Pharma 4.0 Segment by Type in 2022
Figure 2. Pharma 4.0 Segment by Application in 2022
Figure 3. Global Pharma 4.0 Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharma 4.0 Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pharma 4.0 Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharma 4.0 Revenue in 2022
Figure 8. By Type - Global Pharma 4.0 Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pharma 4.0 Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pharma 4.0 Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pharma 4.0 Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pharma 4.0 Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pharma 4.0 Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pharma 4.0 Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pharma 4.0 Revenue Market Share, 2018-2029
Figure 16. US Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pharma 4.0 Revenue Market Share, 2018-2029
Figure 20. Germany Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 21. France Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pharma 4.0 Revenue Market Share, 2018-2029
Figure 28. China Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 32. India Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pharma 4.0 Revenue Market Share, 2018-2029
Figure 34. Brazil Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pharma 4.0 Revenue Market Share, 2018-2029
Figure 37. Turkey Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pharma 4.0 Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Inc Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Laboratories Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GE Healthcare Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boston Scientific Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Medtronic Plc. Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lonza Group AG Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline plc. Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Koninklijke Philips N.V. Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Glatt GmbH Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Vertex Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Johnson & Johnson Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Goodly Innovations Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. QbDVision Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Electrosan Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. GoSilico Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Smart Factory Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ファーマ4.0の世界市場見通し2023年-2029年(Pharma 4.0 Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • サラセミア治療の世界市場見通し2023年-2029年
  • ヒスタミンH4受容体の世界市場見通し2023年-2029年
  • 小児用ADHD治療薬の世界市場見通し2023年-2029年
  • 消費者用ニキビ治療薬の世界市場見通し2023年-2029年
  • 皮膚科用OTC医薬品の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆